The study's objective is to come up with a description of the international financial ecosystem surrounding the development of novel medicines (R&D). This entails charting the types of public and private players involved in research and development of medicines, ascertaining how the research agenda is prepared, establishing the strategies, mechanisms, incentives and drivers of the actors, including investors, as well as how national and international funding for new medicines (including investments and disinvestments, returns, etc.) is shaped.
Tjenesteydelser
27-08-2020 10:00:00
73000000-2 Forsknings- og udviklingsvirksomhed og hermed beslægtet konsulentvirksomhed
73110000-6 Forskning
73200000-4 Konsulentvirksomhed inden for forskning og udvikling
79311400-1 Økonomisk undersøgelse
71620000-0 Analyse
66170000-2 Finansielle konsulentydelser, behandling og clearing af finansielle transaktioner
| Bekendtgørelse | Afsendelsesdato |
|---|---|
| [TNV3F02ContractNotice] (TenderNed) | 29-04-2020 16:00 |
[TNV3F14Corrigendum] (TenderNed)
|
24-06-2020 13:23 |
| [TNV3F03ContractAwardNotice] (TenderNed) | 21-07-2021 16:30 |